[1]
|
Furukawa, K. (2014) Recent Advances in Research on Human Aortic Valve Calcification. Journal of Pharmacological Sciences, 124, 129-137. https://doi.org/10.1254/jphs.13R05CR
|
[2]
|
Otto, C. and Prendergast, B. (2014) Aor-tic-Valve Stenosis—From Patients at Risk to Severe Valve Obstruction. The New England Journal of Medicine, 371, 744-756. https://doi.org/10.1056/NEJMra1313875
|
[3]
|
Nishimura, R., Otto, C., Bonow, R., et al. (2017) 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Dis-ease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 135, e1159-e1195.
https://doi.org/10.1161/CIR.0000000000000503
|
[4]
|
Yutzey, K., Demer, L., Body, S., et al. (2014) Calcific Aortic Valve Disease: A Consensus Summary from the Alliance of Investigators on Calcific Aortic Valve Disease. Arterioscle-rosis, Thrombosis, and Vascular Biology, 34, 2387-2393.
https://doi.org/10.1161/ATVBAHA.114.302523
|
[5]
|
Small, A., Kiss, D., Giri, J., et al. (2017) Biomarkers of Cal-cific Aortic Valve Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 623-632. https://doi.org/10.1161/ATVBAHA.116.308615
|
[6]
|
Erqou, S., Kaptoge, S., Perry, P., et al. (2009) Lipoprotein (a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality. JAMA, 302, 412-423. https://doi.org/10.1001/jama.2009.1063
|
[7]
|
Jang, A., Han, S., Sohn, I., et al. (2020) Lipoprotein (a) and Cardio-vascular Diseases-Revisited. Circulation Journal, 84, 867-874. https://doi.org/10.1253/circj.CJ-20-0051
|
[8]
|
Schmidt, K., Noureen, A., Kronenberg, F., et al. (2016) Structure, Function, and Genetics of Lipoprotein (a). Journal of Lipid Research, 57, 1339-1359. https://doi.org/10.1194/jlr.R067314
|
[9]
|
Arsenault, B., Boekholdt, S., Dubé, M., et al. (2014) Lipoprotein (a) Lev-els, Genotype, and Incident Aortic Valve Stenosis: A Prospective Mendelian Randomization Study and Replication in a Case-Control Cohort. Circulation. Cardiovascular Genetics, 7, 304-310. https://doi.org/10.1161/CIRCGENETICS.113.000400
|
[10]
|
Stewart, B.F., Siscovick, D., Lind, B.K., et al. (1997) Clinical Factors Associated with Calcific Aortic Valve Disease fn1fn1This Study Was Supported in Part by Contracts NO1-HC85079 through HC-850086 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Journal of the American College of Cardiology, 29, 630-634. https://doi.org/10.1016/S0735-1097(96)00563-3
|
[11]
|
Zheng, K., Arsenault, B., Kaiser, Y., et al. (2019) ApoB/ApoA-I Ratio and Lp(a) Associations with Aortic Valve Stenosis Incidence: Insights from the EPIC-Norfolk Prospective Population Study. Journal of the American Heart Association, 8, e013020. https://doi.org/10.1161/JAHA.119.013020
|
[12]
|
Kamstrup, P., Hung, M., Witztum, J., et al. (2017) Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 1570-1578.
https://doi.org/10.1161/ATVBAHA.116.308761
|
[13]
|
刘硕霖. 脂蛋白(a)与主动脉瓣钙化的相关性研究[D]: [硕士学位论文]. 北京: 北京协和医学院, 2020.
|
[14]
|
Losi, M., Brevetti, G., Schiano, V., et al. (2010) Aortic Valve Sclerosis in Patients with Peripheral and/or Coronary Arterial Disease. Echocardiography, 27, 608-612. https://doi.org/10.1111/j.1540-8175.2009.01109.x
|
[15]
|
Szolc, P., Niewiara, Ł., Kawulak, M., et al. (2020) Neu-trophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio as Predictors of Coronary Microcirculatory Disease Occurrence and Outcome in Patients with Chronic Coronary Syndrome and No Significant Coronary Artery Stenosis. Wiadomosci lekarskie (Warsaw, Poland: 1960), 73, 2598-2606.
https://doi.org/10.36740/WLek202012108
|
[16]
|
Avci, A., Elnur, A., Göksel, A., et al. (2014) The Relationship be-tween Neutrophil/Lymphocyte Ratio and Calcific Aortic Stenosis. Echocardiography, 31, 1031-1035. https://doi.org/10.1111/echo.12534
|
[17]
|
Küçükseymen, S., Çağırcı, G., Güven, R., et al. (2017) Is Neutrophyl to Lymphocyte Ratio Really a Useful Marker for All Grades of Degenerative Aortic Stenosis? Türk Kardiyoloji Derneği Arşivi, 45, 506-513.
https://doi.org/10.5543/tkda.2017.32389
|
[18]
|
Akdag, S., Akyol, A., Asker, M., et al. (2015) Plate-let-to-Lymphocyte Ratio May Predict the Severity of Calcific Aortic Stenosis. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 21, 3395-3400. https://doi.org/10.12659/MSM.894774
|
[19]
|
Yayla, Ç., Açikgöz, S., Yayla, K., et al. (2016) The Association be-tween Platelet-to-Lymphocyte Ratio and Inflammatory Markers with the Severity of Aortic Stenosis. Biomarkers in Medicine, 10, 367-373.
https://doi.org/10.2217/bmm-2015-0016
|
[20]
|
Edem, E., Reyhanoğlu, H., Küçükukur, M., et al. (2016) Predictive Value of Platelet-to-Lymphocyte Ratio in Severe Degenerative Aortic Valve Stenosis. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences, 21, 93. https://doi.org/10.4103/1735-1995.192509
|
[21]
|
Bian, W., Wang, Z., Sun, C., et al. (2021) Pathogenesis and Mo-lecular Immune Mechanism of Calcified Aortic Valve Disease. Frontiers in Cardiovascular Medicine, 8, Article ID: 765419. https://doi.org/10.3389/fcvm.2021.765419
|
[22]
|
Pasipoularides, A. (2016) Calcific Aortic Valve Disease: Part 1—Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks. Journal of Cardiovascular Transla-tional Research, 9, 102-118.
https://doi.org/10.1007/s12265-016-9679-z
|
[23]
|
Izquierdo-Gómez, M., Hernández-Betancor, I., García-Niebla, J., et al. (2017) Valve Calcification in Aortic Stenosis: Etiology and Diagnostic Imaging Techniques. BioMed Research In-ternational, 2017, Article ID: 5178631.
https://doi.org/10.1155/2017/5178631
|
[24]
|
Erhart, G., Lamina, C., Lehtimäki, T., et al. (2018) Genetic Factors Ex-plain a Major Fraction of the 50% Lower Lipoprotein(a) Concentrations in Finns. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, 1230-1241.
https://doi.org/10.1161/ATVBAHA.118.310865
|
[25]
|
Mahmut, A., Boulanger, M., El Husseini, D., et al. (2014) Elevated Expression of Lipoprotein-Associated Phospholipase A2 in Calcific Aortic Valve Disease: Implications for Valve Mineralization. Journal of the American College of Cardiology, 63, 460-469. https://doi.org/10.1016/j.jacc.2013.05.105
|
[26]
|
Sun, W., Li, H., Yu, Y., et al. (2009) MEKK3 Is Required for Lysophosphatidic Acid-Induced NF-κB Activation. Cellular Signalling, 21, 1488-1494. https://doi.org/10.1016/j.cellsig.2009.05.007
|
[27]
|
Bouchareb, R., Mahmut, A., Nsaibia, M., et al. (2015) Autotaxin Derived from Lipoprotein (a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve. Circulation, 13, 677-690.
https://doi.org/10.1161/CIRCULATIONAHA.115.016757
|
[28]
|
Libby, P. and Ridker, P. (2004) Inflammation and Atherosclerosis: Role of C-Reactive Protein in Risk Assessment. The American Journal of Medicine, 116, 9S-16S. https://doi.org/10.1016/j.amjmed.2004.02.006
|
[29]
|
Miller, J., Weiss, R. and Heistad, D. (2011) Calcific Aortic Valve Stenosis: Methods, Models, and Mechanisms. Circulation Research, 108, 1392-1412. https://doi.org/10.1161/CIRCRESAHA.110.234138
|
[30]
|
Bogdanova, M., Kostina, A., Zihlavnikova Enayati, K., et al. (2018) Inflammation and Mechanical Stress Stimulate Osteogenic Differentiation of Human Aortic Valve Interstitial Cells. Frontiers in Physiology, 9, Article No. 1635.
https://doi.org/10.3389/fphys.2018.01635
|
[31]
|
Açar, G., Kalkan, M., Avci, A., et al. (2015) The Relation of Plate-let-Lymphocyte Ratio and Coronary Collateral Circulation in Patients with Stable Angina Pectoris and Chronic Total Oc-clusion. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Ap-plied Thrombosis/Hemostasis, 21, 462-468. https://doi.org/10.1177/1076029613508599
|
[32]
|
Langer, H., Weber, C., Gawaz, M., et al. (2013) The Platelet—Thrombosis and Beyond. Thrombosis and Haemostasis, 110, 857-858. https://doi.org/10.1160/TH13-09-0805
|
[33]
|
Smyth, S., Mcever, R., Weyrich, A., et al. (2009) Platelet Functions beyond Hemostasis. Journal of Thrombosis and Haemostasis: JTH, 7, 1759-1766. https://doi.org/10.1111/j.1538-7836.2009.03586.x
|
[34]
|
Blackshear, J., Wysokinska, E., Safford, R., et al. (2013) Indexes of von Willebrand Factor as Biomarkers of Aortic Stenosis Severity (from the Biomarkers of Aortic Stenosis Severity [BASS] Study). The American Journal of Cardiology, 111, 374-381. https://doi.org/10.1016/j.amjcard.2012.10.015
|
[35]
|
Page, C. and Pitchford, S. (2013) Neutrophil and Platelet Com-plexes and Their Relevance to Neutrophil Recruitment and Activation. International Immunopharmacology, 17, 1176-1184. https://doi.org/10.1016/j.intimp.2013.06.004
|
[36]
|
Rossebø, A., Pedersen, T., Boman, K., et al. (2008) Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis. The New England Journal of Medicine, 359, 1343-1356. https://doi.org/10.1056/NEJMoa0804602
|
[37]
|
Chan, K., Teo, K., Dumesnil, J., et al. (2010) Effect of Lipid Lowering with Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Obser-vation: Measuring Effects of Rosuvastatin (Astronomer) Trial. Circulation, 121, 306-314. https://doi.org/10.1161/CIRCULATIONAHA.109.900027
|